BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2006
View Archived Issues
Free radical scavenging activity of nanoceria particles protects against retinal degeneration
Read More
Phase II study for epinastine nasal spray in treatment of seasonal allergic rhinitis
Read More
MLN-518 plus chemotherapy feasible in acute myelogenous leukemia
Read More
DanioLabs reports encouraging progress in Parkinson's disease programs
Read More
Targeting c-Kit with APCK-110 blocks AML cell proliferation in preclinical studies
Read More
Phase II trial set to begin for oral low-dose interferon alpha in HIV oral warts
Read More
ART-123 superior to heparin in disseminated intravascular coagulation
Read More
Snapshots of recent clinical trials in glioma: Part I
Read More
Substance isolated from greater celandine's extract shows antiretroviral activity
Read More
No statistical significance for nalmefene on endpoints in pathological gambling
Read More
Naproxcinod shows favorable 24-hour blood pressure profile
Read More
Preclinical profile of ABT-263: Abbott's novel Bcl-2 inhibitor
Read More
Erythropoietin benefits amyotrophic lateral sclerosis patients
Read More
TRO-19622 well tolerated at doses expected to be effective
Read More
Responses to oblimersen/fludarabine/cyclophosphamide evaluated in CLL study
Read More
Early phase I results with bortezomib and samarium Sm-153 lexidronam reported
Read More
ESPRIT technology focus of new program in Duchenne muscular dystrophy
Read More
Generx to advance to phase III for myocardial ischemia
Read More
Avastin plus interferon therapy improves PFS in metastatic renal cell carcinoma
Read More
Innovive acquires North American rights to tamibarotene
Read More
Intercell completes phase II trial for therapeutic hepatitis C vaccine IC-41
Read More
MethylGene selects MGCD-265 from c-MET kinase program
Read More
MGCD-0103 studied in new phase II trial in high-risk MDS and AML
Read More
Advexin therapy shows survival benefit in patients with abnormal p53 function
Read More
Phase IIb study evaluating Onyvax-P in hormone-resistant prostate cancer
Read More
Protherics to acquire MacroMed
Read More
Novel therapeutic agents for hepatitis C virus infection disclosed in recent patent literature
Read More
Otsuka and Chugai to copromote Pletaal in Japan
Read More
Recent patents impart new therapeutic agents for cancer
Read More
CytoGenix's synDNA vaccine against HIV shows activity in monkeys
Read More
Abilify Injection now available
Read More
EvaMist NDA accepted for review
Read More
Phase II trial under way for GV-1001 in NSCLC
Read More
Preminent tablet launched in Japan
Read More
MuGard receives FDA approval
Read More